CADL: Candel Therapeutics, Inc. Stock

by  •  • Comments Off on CADL: Candel Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 234.19
Enterprise Value ($M) 220.06
Book Value ($M) 12.74
Book Value / Share 0.43
Price / Book 18.38
NCAV ($M) 8.34
NCAV / Share 0.28
Price / NCAV 28.08

Profitability (mra)
Return on Invested Capital (ROIC) -1.07
Return on Assets (ROA) -0.56
Return on Equity (ROE) -0.96

Liquidity (mrq)
Quick Ratio 2.59
Current Ratio 2.59

Balance Sheet (mrq) ($M)
Current Assets 36.80
Assets 41.20
Liabilities 28.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -38.39
Net Income -37.94

Cash Flow Statement (mra) ($M)
Cash From Operations -34.24
Cash from Investing -0.28
Cash from Financing -0.12

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-25 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT P
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 449,173 1,219,695 36.83
2024-05-01 358,707 246,906 145.28
2024-04-30 372,394 139,636 266.69
2024-04-29 73,024 95,455 76.50

(click for more detail)

Similar Companies
BCAB – BioAtla, Inc. BIOR – Biora Therapeutics, Inc.
BTMD – biote Corp. CARA – Cara Therapeutics, Inc.
CARM – Carisma Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io